XENE

NASDAQ · Biotechnology

Xenon Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$54.79

+1.88 (+3.55%)

As of Jun 22, 9:59 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 25 96%

Hold 1 4%

Sell 0 0%

Price Target

Analyst Price Target -63.5% upside

Low Target $12.55

Average Target $19.98

High Target $22.13

Current Price $54.79

Current
$54.79

Target
$19.98

$12.55 $19.98 avg $22.13

Scenario Analysis

Bear Case

$12.55

-77.1%

Low target

Base Case

$19.98

-63.5%

Avg target

Bull Case

$22.13

+-59.6%

High target

Risk/Reward

0.8x

Unfavorable

Price in Context

52-Week High

$63.95

-14.3% from high

52-Week Low

$30.00

+82.6% from low

50-Day SMA

$42.54

+28.8% vs SMA

200-Day SMA

$37.78

+45.0% vs SMA

RSI (14)

57.5

Neutral

Target vs 52W High

$19.98

-68.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+12.0%
AMGN Amgen Inc	Hold	44	50%	$190.87	-44.6%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.1%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.5%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-31.2%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-37.5%